The Costimulatory Molecule CD27 Maintains Clonally Diverse CD8+ T Cell Responses of Low Antigen Affinity to Protect against Viral Variants - ScienceDirect
Expression of classical markers of T cell differentiation. In addition... | Download Scientific Diagram
Pathology Outlines - CD27
The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text
Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue: Trends in Immunology
The CD70-CD27 axis in oncology: the new kids on the block | Journal of Experimental & Clinical Cancer Research | Full Text
CD27: a memory B-cell marker: Immunology Today
Effector Memory Th1 CD4 T Cells Are Maintained in a Mouse Model of Chronic Malaria | PLOS Pathogens
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4+ T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma - ScienceDirect
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
T cell Activation Marker (CD69, CD137, CD27, TRAP/CD40L, CD134) Antibody Panel - Human (ab254024)
Role of CD27/CD70 pathway of activation in immunity and tolerance - Denoeud - 2011 - Journal of Leukocyte Biology - Wiley Online Library
CD27 and CD70 in T cell and B cell activation - ScienceDirect
Frontiers | Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management
PE Mouse Anti-Human CD27
CD27/CD70 Signaling Pathway - Creative Diagnostics
Distinct profiles of activation marker expression on memory CD27 IgG B... | Download Scientific Diagram
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells | Communications Biology
CD27 expression and its association with clinical outcome in children and adults with pro-B acute lymphoblastic leukemia | Blood Cancer Journal
CD27 expression on ovine PBMC populations. Ovine PBMC, derived from n =... | Download Scientific Diagram
CD27 Assay Portfolio Service - Creative Biolabs
Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential | Immunotherapy
